REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects

Brief description of study

The purpose of this research study is to evaluate safety and effectiveness of the LOTUS EdgeTM Valve System when used with the LotusTM or iSleeveTM Introducer Sets for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with severe aortic stenosis who are considered at intermediate risk for surgical valve replacement including those who have a bicuspid native valve.


Clinical Study Identifier: s19-00061
ClinicalTrials.gov Identifier: NCT03618095
Principal Investigator: Mathew R. Williams
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.